Ignite Creation Date:
2024-05-05 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00140569
Status:
COMPLETED
Last Update Posted:
2005-09-01
First Post:
2005-08-31
Brief Title:
Randomized Study for Patients With Follicular Lymphoma Needing Treatment
Sponsor:
Lymphoma Study Association
Organization:
Lymphoma Study Association
Study Overview
Official Title:
Randomized Study for Patients With Follicular Lymphoma Needing Treatment
Status:
COMPLETED
Status Verified Date:
2005-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
2 parallel studies
For young patients 18-60 years randomization between CHVP interferon for 18 months and 4 CHOP followed by autotransplant after TBI
For elderly patients 60 years randomization between CHVP interferon for 18 months and fludarabine 5 days every months for 6 months
For young patients 18-60 years randomization between CHVP interferon for 18 months and 4 CHOP followed by autotransplant after TBI
For elderly patients 60 years randomization between CHVP interferon for 18 months and fludarabine 5 days every months for 6 months
Detailed Description:
2 parallel studies
For young patients 18-60 years randomization between CHVP interferon for 18 months and 4 CHOP followed by autotransplant after TBI
For elderly patients 60 years randomization between CHVP interferon for 18 months and fludarabine 5 days every months for 6 months
For young patients 18-60 years randomization between CHVP interferon for 18 months and 4 CHOP followed by autotransplant after TBI
For elderly patients 60 years randomization between CHVP interferon for 18 months and fludarabine 5 days every months for 6 months
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None